Discovery Health Medical Scheme Faces Challenge Needing 280,000 New Members Annually to Sustain Growth

JOHANNESBURG – Discovery Health Medical Scheme (DHMS) requires an annual influx of 280,000 new members to maintain its current membership levels and offset attrition.

The growth requirement highlights a critical sustainability challenge for the largest private medical scheme in South Africa, where demographic shifts and rising healthcare costs are impacting member retention. The necessity for such high-volume acquisition reflects the systemic pressures facing the private healthcare sector as it balances an aging population with the financial requirements of comprehensive medical coverage.

DHMS operates within a regulatory framework overseen by the Council for Medical Schemes (CMS), a statutory body that sets minimum solvency requirements and polices the Medical Schemes Act to ensure schemes can meet future claims and treat members fairly. The demand for 280,000 new members annually is a function of the “replacement rate” needed to counter members leaving the scheme due to death, retirement, or shifts to lower-cost alternatives.

The current membership dynamics are summarized as follows:

• Annual Target: 280,000 new members required simply to maintain current membership.
• Primary Driver: Member attrition linked to demographic aging and affordability pressures.
• Strategic Impact: Rising acquisition costs, more complex onboarding, and heightened risk of future premium increases.

Membership Attrition and Demographic Pressure

The scale of member replacement needed indicates a volatile and steadily aging membership base. In the South African private health market, attrition is often driven by the “sandwich generation” effect, where middle‑aged members face increasing costs to cover both elderly parents and dependent children, even as their own healthcare needs rise.

The scheme must navigate an environment where medical inflation consistently exceeds the general Consumer Price Index (CPI), putting pressure on employers, households, and policymakers who view private cover as a complement to the strained public health system. As premiums rise to cover the cost of new technologies, specialist care and chronic disease management, a segment of the membership typically migrates toward more affordable, limited‑benefit options or exits the private system entirely.

DHMS needs 280k new members a year just to stand still

This attrition is compounded by the transition of members into retirement, where the cost of coverage often becomes prohibitive relative to fixed pension incomes and limited post‑retirement subsidies. For regulators and the scheme alike, this raises questions about long‑term affordability and whether benefit design and cross‑subsidisation can keep higher‑risk older members in the pool without pricing out younger entrants.

Corporate Strategy, Competition and Policy Relevance

As the flagship medical scheme of Discovery Limited, DHMS is central to a broader ecosystem that integrates health insurance with behavioural incentives via the Vitality programme. This integrated model is designed to reduce long‑term claims by encouraging healthier lifestyles and earlier screening, yet the sheer volume of new members required annually suggests that behavioural interventions alone cannot fully offset the natural attrition of a maturing member base or the structural cost pressures in the system.

The requirement for massive annual growth places DHMS in an increasingly competitive position against other major medical aids and emerging low‑cost benefit options approved by regulators. The acquisition of nearly 300,000 members every year requires aggressive marketing, strong broker relationships and a continuous pipeline of new entrants, typically from the corporate employer‑sponsored market and younger professionals entering formal employment.

The financial viability of the scheme depends on maintaining a favourable “age‑mix.” A younger membership base provides a de facto subsidy for older, higher‑utilisation members, a principle embedded in South Africa’s community‑rating and open‑enrolment rules under the Medical Schemes Act. When attrition occurs primarily among younger, healthier members-or when the growth of new members fails to keep pace with the aging of the existing pool-the risk of premium hikes and benefit downgrades increases, with knock‑on implications for labour negotiations, household budgets and the public health system that must absorb those who fall out of cover.

DHMS continues to operate under the solvency and governance guidelines set by the CMS, while focusing on member acquisition to stabilise its demographic profile. How successfully it manages that balancing act will be closely watched by regulators, competitors and policymakers as they weigh the future role of private medical schemes alongside proposed reforms to South Africa’s health financing landscape.